Citations (261)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Samira Khaledi, Sevda Jafari, Samin Hamidi, Ommoleila Molavi & Soodabeh Davaran. (2020) Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin. Journal of Biomaterials Science, Polymer Edition 31:9, pages 1107-1126.
Read now
Read now
Laura Braconi, Gianluca Bartolucci, Marialessandra Contino, Niccolò Chiaramonte, Roberta Giampietro, Dina Manetti, Maria Grazia Perrone, Maria Novella Romanelli, Nicola Antonio Colabufo, Chiara Riganti, Silvia Dei & Elisabetta Teodori. (2020) 6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 974-992.
Read now
Read now
Shan-Shan Qi, Jia-Hui Sun, Hao-Han Yu & Shu-Qin Yu. (2017) Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy. Drug Delivery 24:1, pages 1909-1926.
Read now
Read now
Jun-Fei Zhang, Jia Liu, Yu Wang & Bin Zhang. (2016) Novel therapeutic strategies for patients with triple-negative breast cancer. OncoTargets and Therapy 9, pages 6519-6528.
Read now
Read now
Yi Zhou, Ruju Wang, Bing Chen, Dan Sun, Yong Hu & Peipei Xu. (2016) Daunorubicin and gambogic acid coloaded cysteamine-CdTe quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo. International Journal of Nanomedicine 11, pages 5429-5442.
Read now
Read now
Antonin Dréan, Lauriane Goldwirt, Maïté Verreault, Michael Canney, Charlotte Schmitt, Jeremy Guehennec, Jean-Yves Delattre, Alexandre Carpentier & Ahmed Idbaih. (2016) Blood-brain barrier, cytotoxic chemotherapies and glioblastoma. Expert Review of Neurotherapeutics 16:11, pages 1285-1300.
Read now
Read now
Qing Miao, Zhiyong Wang, Yuanyuan Zhang, Peipei Miao, Yuanyuan Zhao, Yujie Zhang & Shuangcheng Ma. (2016) In vitro potential modulation of baicalin and baicalein on P-glycoprotein activity and expression in Caco-2 cells and rat gut sacs. Pharmaceutical Biology 54:9, pages 1548-1556.
Read now
Read now
Jian Cheng, Jun Wang, Baoan Chen, Guohua Xia, Xiaohui Cai, Ran Liu, Yanyan Ren, Wen Bao & Xuemei Wang. (2011) A promising strategy for overcoming MDR in tumor by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin. International Journal of Nanomedicine 6, pages 2123-2131.
Read now
Read now
Naseem Akhtar, Abdul Ahad, Roop Kishan Khar, Manu Jaggi, Mohammed Aqil, Zeenat Iqbal, Farhan Jalees Ahmad & Sushama Talegaonkar. (2011) The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review. Expert Opinion on Therapeutic Patents 21:4, pages 561-576.
Read now
Read now
Yan Li, Jezrael L. Revalde, Glen Reid & James W. Paxton. (2010) Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer. Drug Metabolism Reviews 42:4, pages 590-611.
Read now
Read now
Carole Giraud, Sandra Manceau & Jean-Marc Treluyer. (2010) ABC transporters in human lymphocytes: expression, activity and role, modulating factors and consequences for antiretroviral therapies. Expert Opinion on Drug Metabolism & Toxicology 6:5, pages 571-589.
Read now
Read now
Suneet Shukla, Chung-Pu Wu & Suresh V Ambudkar. (2008) Development of inhibitors of ATP-binding cassette drug transporters – present status and challenges. Expert Opinion on Drug Metabolism & Toxicology 4:2, pages 205-223.
Read now
Read now
Brynn T Kvinlaug$suffix/text()$suffix/text() & Brian JP Huntly$suffix/text()$suffix/text(). (2007) Targeting cancer stem cells. Expert Opinion on Therapeutic Targets 11:7, pages 915-927.
Read now
Read now
Articles from other publishers (248)
Ayan Acharya, Mukul Yadav, Mithilesh Nagpure, Sanathanalaxmi Kumaresan & Sankar K. Guchhait. (2024) Molecular medicinal insights into scaffold hopping-based drug discovery success. Drug Discovery Today 29:1, pages 103845.
Crossref
Crossref
Amer E. Alkhalifa, Nour F. Al-Ghraiybah, Julia Odum, John G. Shunnarah, Nataleigh Austin & Amal Kaddoumi. (2023) Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies. International Journal of Molecular Sciences 24:22, pages 16288.
Crossref
Crossref
Laura Braconi, Silvia Dei, Marialessandra Contino, Chiara Riganti, Gianluca Bartolucci, Dina Manetti, Maria Novella Romanelli, Maria Grazia Perrone, Nicola Antonio Colabufo, Stefano Guglielmo & Elisabetta Teodori. (2023) Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers. European Journal of Medicinal Chemistry 259, pages 115716.
Crossref
Crossref
Julia A. Schulz, Anika M.S. Hartz & Björn Bauer. (2023) ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery. Pharmacological Reviews 75:5, pages 815-853.
Crossref
Crossref
Huayu Liu, Mingqi Liu, Yanan Zhao & Ran Mo. (2023) Nanomedicine strategies to counteract cancer stemness and chemoresistance. Exploration of Targeted Anti-tumor Therapy, pages 630-656.
Crossref
Crossref
Negin Namazian Jam, Felix Gottlöber, Melanie Hempel, Yuliya Dzekhtsiarova, Stephan Behrens, Frank Sonntag, Jan Sradnick, Christian Hugo & Florian Schmieder. (2023) Microphysiological Conditions Do Not Affect MDR1-Mediated Transport of Rhodamine 123 above an Artificial Proximal Tubule. Biomedicines 11:7, pages 2045.
Crossref
Crossref
Anton Lindberg, Melissa Chassé, Cassis Varlow, Anna Pees & Neil Vasdev. (2023) Strategies for designing novel positron emission tomography (PET) radiotracers to cross the blood–brain barrier. Journal of Labelled Compounds and Radiopharmaceuticals 66:9, pages 205-221.
Crossref
Crossref
Jihoon Lee, Min-Koo Choi & Im-Sook Song. (2023) Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting. Pharmaceuticals 16:6, pages 802.
Crossref
Crossref
Severin Mairinger, Irene Hernández-Lozano, Thomas Filip, Mathilde Löbsch, Johann Stanek, Markus Zeitlinger, Marcus Hacker, Nicolas Tournier, Thomas Wanek, Carsten Ehrhardt & Oliver Langer. (2023) Influence of P-glycoprotein on pulmonary disposition of the model substrate [11C]metoclopramide assessed by PET imaging in rats. European Journal of Pharmaceutical Sciences 183, pages 106404.
Crossref
Crossref
Łukasz Biegała, Arkadiusz Gajek, Agnieszka Marczak & Aneta Rogalska. (2023) Olaparib-Resistant BRCA2MUT Ovarian Cancer Cells with Restored BRCA2 Abrogate Olaparib-Induced DNA Damage and G2/M Arrest Controlled by the ATR/CHK1 Pathway for Survival. Cells 12:7, pages 1038.
Crossref
Crossref
Chang Hyun Kim, Sangkil Lee, Ji Yeh Choi, Min Jeong Lyu, Hyun Min Jung, Yoon Tae Goo, Myung Joo Kang & Young Wook Choi. (2023) Functionalized Lipid Nanocarriers for Simultaneous Delivery of Docetaxel and Tariquidar to Chemoresistant Cancer Cells. Pharmaceuticals 16:3, pages 349.
Crossref
Crossref
Hui Li, Sheng-Lie Zhang, Yan-Han Jia, Qian Li, Zi-Wen Feng, Shi-Duo Zhang, Wei Zheng, Ye-Ling Zhou, Lin-Lin Li, Xue-Chun Liu, Ya-Qiong Chen, Hui Peng, Qi-Dong You & Xiao-Li Xu. (2023)
Imidazo[1,2-
a
]Pyridine Derivatives as Novel Dual-Target Inhibitors of ABCB1 and ABCG2 for Reversing Multidrug Resistance
. Journal of Medicinal Chemistry 66:4, pages 2804-2831.
Crossref
Crossref
Bo Liu, Xueni Yu, Liping Liu, Lei Wang, Jie Wang, Qianqian Huang, Zhongliang Xu, Cheng Luo, Liguang Lou, Wei Huang & Weibo Yang. (2023) Modular Biomimetic Strategy Enabled Discovery of Simplified Pseudo-Natural Macrocyclic P-Glycoprotein Inhibitors Capable of Overcoming Multidrug Resistance. Journal of Medicinal Chemistry 66:4, pages 2550-2565.
Crossref
Crossref
Wenqin Sun, Iris L. K. Wong, Helen Ka-Wai Law, Xiaochun Su, Terry C. F. Chan, Gege Sun, Xinqing Yang, Xingkai Wang, Tak Hang Chan, Shengbiao Wan & Larry M. C. Chow. (2023) In Vivo Reversal of P-Glycoprotein-Mediated Drug Resistance in a Breast Cancer Xenograft and in Leukemia Models Using a Novel, Potent, and Nontoxic Epicatechin EC31. International Journal of Molecular Sciences 24:5, pages 4377.
Crossref
Crossref
Jingyi Fan, Kenneth Kin Wah To, Zhe-Sheng Chen & Liwu Fu. (2023) ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance. Drug Resistance Updates 66, pages 100905.
Crossref
Crossref
Daniel Perez-Perez, Hiram Luna-Munguia & Heidrun Potschka. 2023. Pharmacoresistance in Epilepsy. Pharmacoresistance in Epilepsy
499
511
.
Alan Talevi. 2023. Pharmacoresistance in Epilepsy. Pharmacoresistance in Epilepsy
429
451
.
Elisabetta Teodori, Laura Braconi, Dina Manetti, Maria Novella Romanelli & Silvia Dei. (2022) The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that
Act as Multidrug Resistance (MDR) Reversers. Current Topics in Medicinal Chemistry 22:31, pages 2535-2569.
Crossref
Crossref
Tsz Cheung Chong, Iris L. K. Wong, Jiahua Cui, Man Chun Law, Xuezhen Zhu, Xuesen Hu, Jason W. Y. Kan, Clare S. W. Yan, Tak Hang Chan & Larry M. C. Chow. (2022) Characterization of a Potent, Selective, and Safe Inhibitor, Ac15(Az8)2, in Reversing Multidrug Resistance Mediated by Breast Cancer Resistance Protein (BCRP/ABCG2). International Journal of Molecular Sciences 23:21, pages 13261.
Crossref
Crossref
Severin Mairinger, Irene Hernández-Lozano, Thomas Filip, Michael Sauberer, Mathilde Löbsch, Johann Stanek, Thomas Wanek, Johannes A. Sake, Thomas Pekar, Carsten Ehrhardt & Oliver Langer. (2022) Impact of P-gp and BCRP on pulmonary drug disposition assessed by PET imaging in rats. Journal of Controlled Release 349, pages 109-117.
Crossref
Crossref
Sebastian P. A. Rosser, Caroline Atkinson, Christa E. Nath & Jamie I. Fletcher. (2022) Quantification of vincristine and tariquidar by liquid chromatography‐tandem mass spectrometry in mouse whole blood using volumetric absorptive microsampling for pharmacokinetic applications. Journal of Separation Science 45:14, pages 2508-2519.
Crossref
Crossref
Chang Hyun Kim, Tae Hwa Lee, Byoung Deok Kim, Hyeon Kyun Kim, Min Jeong Lyu, Hyun Min Jung, Yoon Tae Goo, Myung Joo Kang, Sangkil Lee & Young Wook Choi. (2022) Co-administration of tariquidar using functionalized nanostructured lipid carriers overcomes resistance to docetaxel in multidrug resistant MCF7/ADR cells. Journal of Drug Delivery Science and Technology 71, pages 103323.
Crossref
Crossref
Larry M.C. ChowTak Hang Chan. (2022) ATP-binding cassette (ABC) transporter proteins, multidrug resistance, and novel flavonoid dimers as potent, nontoxic, and selective inhibitors. Canadian Journal of Chemistry 100:2, pages 85-97.
Crossref
Crossref
Irene Hernández-Lozano, Severin Mairinger, Thomas Filip, Michael Sauberer, Thomas Wanek, Johann Stanek, Johannes A. Sake, Thomas Pekar, Carsten Ehrhardt & Oliver Langer. (2022) PET imaging to assess the impact of P-glycoprotein on pulmonary drug delivery in rats. Journal of Controlled Release 342, pages 44-52.
Crossref
Crossref
Yusuke Murase, Kenji Hosoya, Takachika Sato, Sangho Kim & Masahiro Okumura. (2022) Antitumor activity of the dual PI3K/mTOR inhibitor gedatolisib and the involvement of ABCB1 in gedatolisib resistance in canine tumor cells. Oncology Reports 47:4.
Crossref
Crossref
Sameer Urgaonkar, Kamil Nosol, Ahmed M. Said, Nader N. Nasief, Yahao Bu, Kaspar P. Locher, Johnson Y. N. Lau & Michael P. Smolinski. (2021) Discovery and Characterization of Potent Dual P-Glycoprotein and CYP3A4 Inhibitors: Design, Synthesis, Cryo-EM Analysis, and Biological Evaluations. Journal of Medicinal Chemistry 65:1, pages 191-216.
Crossref
Crossref
Francisco J. Hicke, Adrián Puerta, Jelena Dinić, Milica Pešić, José M. Padrón, Óscar López & José G. Fernández-Bolaños. (2022) Straightforward access to novel mitochondriotropics derived from 2-arylethanol as potent and selective antiproliferative agents. European Journal of Medicinal Chemistry 228, pages 113980.
Crossref
Crossref
Surabhi Talele, Afroz S. Mohammad, Julia A. Schulz, Bjoern Bauer, Anika M. S. Hartz, Jann N. Sarkaria & William F. Elmquist. 2022. Drug Delivery to the Brain. Drug Delivery to the Brain
723
762
.
Parul Sharma, Navneet Singh & Siddharth Sharma. (2021) ATP binding cassette transporters and cancer: revisiting their controversial role. Pharmacogenomics 22:18, pages 1211-1235.
Crossref
Crossref
Iris L.K. Wong, Xing-kai Wang, Zhen Liu, Wenqin Sun, Fu-xing Li, Bao-chao Wang, Peng Li, Sheng-biao Wan & Larry M.C. Chow. (2021) Synthesis and evaluation of stereoisomers of methylated catechin and epigallocatechin derivatives on modulating P-glycoprotein-mediated multidrug resistance in cancers. European Journal of Medicinal Chemistry 226, pages 113795.
Crossref
Crossref
Zi‐Ning Lei, Qiu‐Xu Teng, Zhuo‐Xun Wu, Feng‐Feng Ping, Peng Song, John N.D. Wurpel & Zhe‐Sheng Chen. (2021) Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR/Cas9 system in SW620/Ad300 colorectal cancer cells. MedComm 2:4, pages 765-777.
Crossref
Crossref
Liang Han. (2021) Modulation of the Blood–Brain Barrier for Drug Delivery to Brain. Pharmaceutics 13:12, pages 2024.
Crossref
Crossref
Samantha Buongervino, Maria V. Lane, Emily Garrigan, Doncho V. Zhelev, Dimiter S. Dimitrov & Kristopher R. Bosse. (2021) Antibody–Drug Conjugate Efficacy in Neuroblastoma: Role of Payload, Resistance Mechanisms, Target Density, and Antibody Internalization. Molecular Cancer Therapeutics 20:11, pages 2228-2239.
Crossref
Crossref
Iris L.K. Wong, Xuezhen Zhu, Kin-Fai Chan, Zhen Liu, Chin-Fung Chan, Tsun Sing Chow, Tsz Cheung Chong, Man Chun Law, Jiahua Cui, Larry M.C. Chow & Tak Hang Chan. (2021) Flavonoid Monomers as Potent, Nontoxic, and Selective Modulators of the Breast Cancer Resistance Protein (ABCG2). Journal of Medicinal Chemistry 64:19, pages 14311-14331.
Crossref
Crossref
Alan P. Lombard, Wei Lou, Cameron M. Armstrong, Leandro S. D'Abronzo, Shu Ning, Christopher P. Evans & Allen C. Gao. (2021)
Activation of the
ABCB1
Amplicon in Docetaxel- and Cabazitaxel-Resistant Prostate Cancer Cells
. Molecular Cancer Therapeutics 20:10, pages 2061-2070.
Crossref
Crossref
Sol-Bi Shin, Dae-Hoon Kim, Da-Eun Kim, Mark Borris D. Aldonza, Yoosik Kim & Hyungshin Yim. (2021) Dual Targeting of EGFR with PLK1 Exerts Therapeutic Synergism in Taxane-Resistant Lung Adenocarcinoma by Suppressing ABC Transporters. Cancers 13:17, pages 4413.
Crossref
Crossref
Yan-Jye Shyong, Yadira Sepulveda, Arnold Garcia, Nathan M. Samskey, Zoran Radic, Rakesh K. Sit, K. Barry Sharpless, Jeremiah D. Momper & Palmer Taylor. (2021) Enhancing Target Tissue Levels and Diminishing Plasma Clearance of Ionizing Zwitterionic Antidotes in Organophosphate Exposures. Journal of Pharmacology and Experimental Therapeutics 378:3, pages 315-321.
Crossref
Crossref
Ya‐Xuan Zhu, Hao‐Ran Jia, Qiu‐Yi Duan & Fu‐Gen Wu. (2021) Nanomedicines for combating multidrug resistance of cancer. WIREs Nanomedicine and Nanobiotechnology 13:5.
Crossref
Crossref
Tatyana Grigoreva, Aleksandra Sagaidak, Angelina Romanova, Daria Novikova, Aleksander Garabadzhiu & Viacheslav Tribulovich. (2021) Establishment of drug-resistant cell lines under the treatment with chemicals acting through different mechanisms. Chemico-Biological Interactions 344, pages 109510.
Crossref
Crossref
Xu Wu, Chun Yin, Jiang Ma, Stella Chai, Chunyuan Zhang, Sheng Yao, Onat Kadioglu, Thomas Efferth, Yang Ye, Kenneth Kin-Wah To & Ge Lin. (2021) Polyoxypregnanes as safe, potent, and specific ABCB1-inhibitory pro-drugs to overcome multidrug resistance in cancer chemotherapy in vitro and in vivo. Acta Pharmaceutica Sinica B 11:7, pages 1885-1902.
Crossref
Crossref
Myriam El Biali, Rudolf Karch, Cécile Philippe, Helmuth Haslacher, Nicolas Tournier, Marcus Hacker, Markus Zeitlinger, Doreen Schmidl, Oliver Langer & Martin Bauer. (2021) ABCB1 and ABCG2 Together Limit the Distribution of ABCB1/ABCG2 Substrates to the Human Retina and the ABCG2 Single Nucleotide Polymorphism Q141K (c.421C> A) May Lead to Increased Drug Exposure. Frontiers in Pharmacology 12.
Crossref
Crossref
Rachel L. Mynott & Craig T. Wallington-Beddoe. (2021) Drug and Solute Transporters in Mediating Resistance to Novel Therapeutics in Multiple Myeloma. ACS Pharmacology & Translational Science 4:3, pages 1050-1065.
Crossref
Crossref
Luca Jaromi, Veronika Csongei, Monika Vesel, ElHusseiny Mohamed Mahmud Abdelwahab, Amina Soltani, Zsofia Torok, Gabor Smuk, Veronika Sarosi & Judit Erzsebet Pongracz. (2021) KRAS and EGFR Mutations Differentially Alter ABC Drug Transporter Expression in Cisplatin-Resistant Non-Small Cell Lung Cancer. International Journal of Molecular Sciences 22:10, pages 5384.
Crossref
Crossref
Vrinda Gote, Anantha Ram Nookala, Pradeep Kumar Bolla & Dhananjay Pal. (2021) Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue. International Journal of Molecular Sciences 22:9, pages 4673.
Crossref
Crossref
James W. McCormick, Lauren Ammerman, Gang Chen, Pia D. Vogel & John G. Wise. (2021) Transport of Alzheimer’s associated amyloid-β catalyzed by P-glycoprotein. PLOS ONE 16:4, pages e0250371.
Crossref
Crossref
Michael P. Smolinski, Sameer Urgaonkar, Laura Pitzonka, Murray Cutler, GwanSun Lee, Kwee Hyun Suh & Johnson Y. N. Lau. (2021) Discovery of Encequidar, First-in-Class Intestine Specific P-glycoprotein Inhibitor. Journal of Medicinal Chemistry 64:7, pages 3677-3693.
Crossref
Crossref
Hongyan Mu, Shuai Tang, Quan Zuo, Min Huang & Weimin Zhao. (2021)
Dihydro-β-agarofuran-Type Sesquiterpenoids from the Seeds of
Celastrus virens
and Their Multidrug Resistance Reversal Activity against the KB/VCR Cell Line
. Journal of Natural Products 84:3, pages 588-600.
Crossref
Crossref
Natalia Kasica, Piotr Jakubowski & Jerzy Kaleczyc. (2021) P-Glycoprotein Inhibitor Tariquidar Plays an Important Regulatory Role in Pigmentation in Larval Zebrafish. Cells 10:3, pages 690.
Crossref
Crossref
Wei Wang, Ze Liang, Pengfei Ma, Qi Zhao, Mengyuan Dai, Jie Zhu, Xu Han, Hong Xu, Qingyan Chang & Yuhong Zhen. (2021) Application of CRISPR/Cas9 System to Reverse ABC-Mediated Multidrug Resistance. Bioconjugate Chemistry 32:1, pages 73-81.
Crossref
Crossref
Farnoosh Kazemi, Isaac Karimi & Namdar Yousofvand. (2021) Molecular docking study of lignanamides from Cannabis sativa against P-glycoprotein. In Silico Pharmacology 9:1.
Crossref
Crossref
Liora Colobatiu, Laura Gavrilas & Andrei Mocan. 2021. pH-Interfering Agents as Chemosensitizers in Cancer Therapy. pH-Interfering Agents as Chemosensitizers in Cancer Therapy
147
165
.
Pascalle Mossel, Anna L. Bartels, Peter Paul de Deyn & Gert Luurtsema. 2021. PET and SPECT in Psychiatry. PET and SPECT in Psychiatry
45
81
.
Lara García-Varela, Pascalle Mossel, Marcel Benadiba, Heli Savolainen, Nicola A. Colabufo, Albert D. Windhorst, Philip Elsinga, Aren van Waarde & Gert Luurtsema. 2021. PET and SPECT of Neurobiological Systems. PET and SPECT of Neurobiological Systems
809
850
.
Arthur G. Roberts. 2021. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
193
234
.
Hang Zhang, Haiwei Xu, Charles R. AshbyJr.Jr., Yehuda G. Assaraf, Zhe‐Sheng Chen & Hong‐Min Liu. (2020) Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp). Medicinal Research Reviews 41:1, pages 525-555.
Crossref
Crossref
Jinling Yu, Fengli Hu, Qiankun Zhu, Xiaodong Li, Haiyang Ren, Shengjie Fan, Bo Qian, Bo Zhai & Dongdong Yang. (2020) PD-L1 monoclonal antibody-decorated nanoliposomes loaded with Paclitaxel and P-gp transport inhibitor for the synergistic chemotherapy against multidrug resistant gastric cancers. Nanoscale Research Letters 15:1.
Crossref
Crossref
Jiun-I Lai, Yu-Jhen Tseng, Ming-Huang Chen, Chi-Ying F. Huang & Peter Mu-Hsin Chang. (2020) Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics. Frontiers in Oncology 10.
Crossref
Crossref
Rui Li, Chengyong Dong, Keqiu Jiang, Rui Sun, Yang Zhou, Zeli Yin, Jiaxin Lv, Junlin Zhang, Qi Wang & Liming Wang. (2020) Rab27B enhances drug resistance in hepatocellular carcinoma by promoting exosome-mediated drug efflux. Carcinogenesis 41:11, pages 1583-1591.
Crossref
Crossref
Thomas Wanek, Viktoria Zoufal, Mirjam Brackhan, Markus Krohn, Severin Mairinger, Thomas Filip, Michael Sauberer, Johann Stanek, Thomas Pekar, Jens Pahnke & Oliver Langer. (2020) Brain Distribution of Dual ABCB1/ABCG2 Substrates Is Unaltered in a Beta-Amyloidosis Mouse Model. International Journal of Molecular Sciences 21:21, pages 8245.
Crossref
Crossref
M. Asif, M. Usman, Shahid Ayub, Sahar Farhat, Zilli Huma, Jawad Ahmed, Mohammad A. Kamal, Deema Hussein, Aneela Javed & Ishaq Khan. (2020) Role of ATP-Binding Cassette Transporter Proteins in CNS Tumors: Resistance- Based Perspectives and Clinical Updates. Current Pharmaceutical Design 26:37, pages 4747-4763.
Crossref
Crossref
Manu M. Joseph, Adukkadan N. Ramya, Vineeth M. Vijayan, Jyothi B. Nair, Blossom T. Bastian, Raveendran K. Pillai, Sreelekha T. Therakathinal & Kaustabh K. Maiti. (2020) Targeted Theranostic Nano Vehicle Endorsed with Self‐Destruction and Immunostimulatory Features to Circumvent Drug Resistance and Wipe‐Out Tumor Reinitiating Cancer Stem Cells. Small 16:38, pages 2003309.
Crossref
Crossref
Joshua Silva, Sheraz Khoja, Liana Asatryan, Eunjoo Pacifici & Daryl L. Davies. (2020) A novel pharmacotherapy approach using P-glycoprotein (PGP/ABCB1) efflux inhibitor combined with ivermectin to reduce alcohol drinking and preference in mice. Alcohol 86, pages 1-8.
Crossref
Crossref
Sonu Kumar Gupta, Priyanka Singh, Villayat Ali & Malkhey Verma. (2020) Role of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy. Oncology Reviews 14:2.
Crossref
Crossref
Marina Sagnou, Fedor N. Novikov, Ekaterina S. Ivanova, Polyxeni Alexiou, Victor S. Stroylov, Ilya Y. Titov, Victor V. Tatarskiy, Murad S. Vagida, Maria Pelecanou, Alexander A. Shtil & Ghermes G. Chilov. (2020) Novel curcumin derivatives as P-glycoprotein inhibitors: Molecular modeling, synthesis and sensitization of multidrug resistant cells to doxorubicin. European Journal of Medicinal Chemistry 198, pages 112331.
Crossref
Crossref
Sara Batista do Nascimento, Mariana de Lima Nascimento, Laís Lobato de Araújo, Flávio Martins de Oliveira, Maria do Carmo Vieira, Joaquim Maurício Duarte-Almeida, João Máximo Siqueira, Isabela da Costa César, Hartmut Derendorf & Whocely Victor de Castro. (2020) Evaluation of the Effects of Maytenus ilicifolia on the Activities of Cytochrome P450 3A and P-glycoprotein. Current Drug Metabolism 21:4, pages 281-290.
Crossref
Crossref
Joanna Kopecka, Martina Godel, Silvia Dei, Roberta Giampietro, Dimas Carolina Belisario, Muhlis Akman, Marialessandra Contino, Elisabetta Teodori & Chiara Riganti. (2020) Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death. Cells 9:4, pages 1033.
Crossref
Crossref
Tatjana P. Stanojkovic & Sanja Milovic. (2020) A Marine Natural Products as Modulators of Multidrug Resistance. Journal of Cancer Research Updates 9:1, pages 96-101.
Crossref
Crossref
Irene Hernández Lozano, Martin Bauer, Beatrix Wulkersdorfer, Alexander Traxl, Cécile Philippe, Maria Weber, Stephanie Häusler, Bruno Stieger, Walter Jäger, Severin Mairinger, Thomas Wanek, Marcus Hacker, Markus Zeitlinger & Oliver Langer. (2019)
Measurement of Hepatic ABCB1 and ABCG2 Transport Activity with [
11
C]Tariquidar and PET in Humans and Mice
. Molecular Pharmaceutics 17:1, pages 316-326.
Crossref
Crossref
Kenneth K.W. To, Mingxia Wu, Christy W.S. Tong & Wei Yan. 2020. Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies. Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies
35
55
.
Gautham Gampa, Surabhi Talele, Minjee Kim, Afroz Mohammad, Jessica Griffith & William F. Elmquist. 2020. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy
277
301
.
Xingping Quan, Hongzhi Du, Jingjing Xu, Xiaoying Hou, Xiaofeng Gong, Yao Wu, Yuqi Zhou, Jingwei Jiang, Ligong Lu, Shengtao Yuan, Xiangyu Yang, Lei Shi & Li Sun. (2019) Novel Quinoline Compound Derivatives of NSC23925 as Potent Reversal Agents Against P-Glycoprotein-Mediated Multidrug Resistance. Frontiers in Chemistry 7.
Crossref
Crossref
Beatrix Wulkersdorfer, Martin Bauer, Rudolf Karch, Harald Stefanits, Cécile Philippe, Maria Weber, Thomas Czech, Marie-Claude Menet, Xavier Declèves, Johannes A. Hainfellner, Matthias Preusser, Marcus Hacker, Markus Zeitlinger, Markus Müller & Oliver Langer. (2019) Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography. EJNMMI Research 9:1.
Crossref
Crossref
Wen Hou, Ying Meng, Xiao-Fang Xu, Zhi-Xing Huang, Jun Liu, Zhen-Ya Wang, Jing Lin & Wei-Min Chen. (2019) Novel virosecurinine bivalent mimetics as potent reversal agents against P-glycoprotein-mediated multidrug resistance. European Journal of Medicinal Chemistry 183, pages 111726.
Crossref
Crossref
Jing-Quan Wang, Bo Wang, Zi-Ning Lei, Qiu-Xu Teng, Jonathan Y. Li, Wei Zhang, Ning Ji, Chao-Yun Cai, Li-Ying Ma, Hong-Min Liu & Zhe-Sheng Chen. (2019) Derivative of 5-cyano-6-phenylpyrimidin antagonizes ABCB1- and ABCG2-mediated multidrug resistance. European Journal of Pharmacology 863, pages 172611.
Crossref
Crossref
Yae Eun Chong, Manting Chiang, Kiran Deshpande, Simon Haroutounian, Leonid Kagan & Jong Bong Lee. (2019) Simultaneous quantification of ondansetron and tariquidar in rat and human plasma using a high performance liquid chromatography‐ultraviolet method. Biomedical Chromatography 33:11.
Crossref
Crossref
Jiahua Cui, Xiaoyang Liu & Larry M.C. Chow. (2019) Flavonoids as P-gp Inhibitors: A Systematic Review of SARs. Current Medicinal Chemistry 26:25, pages 4799-4831.
Crossref
Crossref
Shirin Mollazadeh, Amirhossein Sahebkar, Fatemeh Kalalinia, Javad Behravan & Farzin Hadizadeh. (2019) Synthesis, in silico and in vitro studies of new 1,4-dihydropiridine derivatives for antitumor and P-glycoprotein inhibitory activity. Bioorganic Chemistry 91, pages 103156.
Crossref
Crossref
Sravanthi Shastri, Bhaswati Chatterjee & Suman S. Thakur. (2019) Achievements in Cancer Research and its Therapeutics in Hundred Years. Current Topics in Medicinal Chemistry 19:17, pages 1545-1562.
Crossref
Crossref
Amit Kumar & Vikas Jaitak. (2019) Natural products as multidrug resistance modulators in cancer. European Journal of Medicinal Chemistry 176, pages 268-291.
Crossref
Crossref
Mutta Kairuki, Qianqian Qiu, Miaobo Pan, Qifei Li, Jiaqi Zhou, Hesham Ghaleb, Wenlong Huang, Hai Qian & Cheng Jiang. (2019) Designed P-glycoprotein inhibitors with triazol-tetrahydroisoquinoline-core increase doxorubicin-induced mortality in multidrug resistant K562/A02 cells. Bioorganic & Medicinal Chemistry 27:15, pages 3347-3357.
Crossref
Crossref
Nandhitha Subramanian, Alexandra Schumann-Gillett, Alan E. Mark & Megan L. O’Mara. (2018) Probing the Pharmacological Binding Sites of P-Glycoprotein Using Umbrella Sampling Simulations. Journal of Chemical Information and Modeling 59:5, pages 2287-2298.
Crossref
Crossref
Matthew T. McKenna, Jared A. Weis, Vito Quaranta & Thomas E. Yankeelov. (2019) Leveraging Mathematical Modeling to Quantify Pharmacokinetic and Pharmacodynamic Pathways: Equivalent Dose Metric. Frontiers in Physiology 10.
Crossref
Crossref
Alexander Traxl, Severin Mairinger, Thomas Filip, Michael Sauberer, Johann Stanek, Stefan Poschner, Walter Jäger, Viktoria Zoufal, Gaia Novarino, Nicolas Tournier, Martin Bauer, Thomas Wanek & Oliver Langer. (2019)
Inhibition of ABCB1 and ABCG2 at the Mouse Blood–Brain Barrier with Marketed Drugs To Improve Brain Delivery of the Model ABCB1/ABCG2 Substrate [
11
C]erlotinib
. Molecular Pharmaceutics 16:3, pages 1282-1293.
Crossref
Crossref
Haneen Amawi, Hong-May Sim, Amit K. Tiwari, Suresh V. Ambudkar & Suneet Shukla. 2019. Drug Transporters in Drug Disposition, Effects and Toxicity. Drug Transporters in Drug Disposition, Effects and Toxicity
549
580
.
Liming Chang, Mengwu Xiao, Linlin Yang, Shuai Wang, Sai-Qi Wang, Andreas Bender, Aixi Hu, Zhe-Sheng Chen, Bin Yu & Hong-Min Liu. (2018) Discovery of a non-toxic [1,2,4]triazolo[1,5-a]pyrimidin-7-one (WS-10) that modulates ABCB1-mediated multidrug resistance (MDR). Bioorganic & Medicinal Chemistry 26:22, pages 5974-5985.
Crossref
Crossref
Xiaodong Ma, Mengqi Hu, Hao Wang & Jiaming Li. (2018) Discovery of traditional Chinese medicine monomers and their synthetic intermediates, analogs or derivatives for battling P-gp-mediated multi-drug resistance. European Journal of Medicinal Chemistry 159, pages 381-392.
Crossref
Crossref
Denzil Furtado, Mattias Björnmalm, Scott Ayton, Ashley I. Bush, Kristian Kempe & Frank Caruso. (2018) Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases. Advanced Materials 30:46.
Crossref
Crossref
Yuqiong Xia, Mei Fang, Jingyu Dong, Chunzhong Xu, Zhen Liao, Pengbo Ning & Qi Zeng. (2018) pH sensitive liposomes delivering tariquidar and doxorubicin to overcome multidrug resistance of resistant ovarian cancer cells. Colloids and Surfaces B: Biointerfaces 170, pages 514-520.
Crossref
Crossref
Liming Chang, Mengwu Xiao, Linlin Yang, Shuai Wang, Sai-Qi Wang, Andreas Bender, Aixi Hu, Zhe-Sheng Chen, Bin Yu & Hong-Min Liu. (2018) Discovery of a non-toxic [1,2,4]triazolo[1,5-a]pyrimidin-7-one (WS-10) that modulates ABCB1-mediated multidrug resistance (MDR). Bioorganic & Medicinal Chemistry 26:18, pages 5006-5017.
Crossref
Crossref
Peter Matzneller, Manuel Kussmann, Sabine Eberl, Alexandra Maier-Salamon, Walter Jäger, Martin Bauer, Oliver Langer, Markus Zeitlinger & Wolfgang Poeppl. (2018) Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration. European Journal of Drug Metabolism and Pharmacokinetics 43:5, pages 599-606.
Crossref
Crossref
Norihiko Sugisawa, Shinobu Ohnuma, Hirofumi Ueda, Megumi Murakami, Kyoko Sugiyama, Kosuke Ohsawa, Kuniyuki Kano, Hidetoshi Tokuyama, Takayuki Doi, Junken Aoki, Masaharu Ishida, Katsuyoshi Kudoh, Takeshi Naitoh, Suresh V. Ambudkar & Michiaki Unno. (2018) Novel Potent ABCB1 Modulator, Phenethylisoquinoline Alkaloid, Reverses Multidrug Resistance in Cancer Cell. Molecular Pharmaceutics 15:9, pages 4021-4030.
Crossref
Crossref
Chengqiong Mao, Yan Zhao, Fang Li, Zibo Li, Shaomin Tian, Waldemar Debinski & Xin Ming. (2018) P-glycoprotein targeted and near-infrared light-guided depletion of chemoresistant tumors. Journal of Controlled Release 286, pages 289-300.
Crossref
Crossref
Minjee Kim, Sani H. Kizilbash, Janice K. Laramy, Gautham Gampa, Karen E. Parrish, Jann N. Sarkaria & William F. Elmquist. (2018) Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine. Pharmaceutical Research 35:9.
Crossref
Crossref
Aleksandra Adamska & Marco Falasca. (2018) ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?. World Journal of Gastroenterology 24:29, pages 3222-3238.
Crossref
Crossref
Katarina Elefantova, Boris Lakatos, Jana Kubickova, Zdena Sulova & Albert Breier. (2018) Detection of the Mitochondrial Membrane Potential by the Cationic Dye JC-1 in L1210 Cells with Massive Overexpression of the Plasma Membrane ABCB1 Drug Transporter. International Journal of Molecular Sciences 19:7, pages 1985.
Crossref
Crossref
Amol Mehta, Chidiebere U. Awah & Adam M. Sonabend. (2018) Topoisomerase II Poisons for Glioblastoma; Existing Challenges and Opportunities to Personalize Therapy. Frontiers in Neurology 9.
Crossref
Crossref
Silvia Dei, Marcella Coronnello, Gianluca Bartolucci, Dina Manetti, Maria Novella Romanelli, Chatchanok Udomtanakunchai, Milena Salerno & Elisabetta Teodori. (2018) Design and synthesis of new potent N,N -bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents. European Journal of Medicinal Chemistry 147, pages 7-20.
Crossref
Crossref
Amer AlamRaphael KüngJulia KowalRobert A. McLeodNina TrempEugenia V. Broude, Igor B. Roninson, Henning Stahlberg & Kaspar P. Locher. (2018) Structure of a zosuquidar and UIC2-bound human-mouse chimeric ABCB1. Proceedings of the National Academy of Sciences 115:9.
Crossref
Crossref
K. Donskow-Łysoniewska, K. Krawczak, E. Kozłowska & M. Doligalska. (2017) The intestinal nematode inhibits T-cell reactivity by targeting P-GP activity. Parasite Immunology 39:12, pages e12497.
Crossref
Crossref
Ranjeet Prasad Dash, R. Jayachandra Babu & Nuggehally R. Srinivas. (2017) Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies. European Journal of Drug Metabolism and Pharmacokinetics 42:6, pages 915-933.
Crossref
Crossref
Ye Li, Tongkai Chen, Xiaoqing Miao, Xiang Yi, Xueqing Wang, Haitao Zhao, Simon Ming-Yuen Lee & Ying Zheng. (2017) Zebrafish: A promising in vivo model for assessing the delivery of natural products, fluorescence dyes and drugs across the blood-brain barrier. Pharmacological Research 125, pages 246-257.
Crossref
Crossref
Miriam Durante, Maria Frosini, Fabio Fusi, Annalisa Neri, Claudia Sticozzi & Simona Saponara. (2017) In vitro vascular toxicity of tariquidar, a potential tool for in vivo PET studies. Toxicology in Vitro 44, pages 241-247.
Crossref
Crossref
Martin Bauer, Beatrix Wulkersdorfer, Rudolf Karch, Cécile Philippe, Walter Jäger, Johann Stanek, Wolfgang Wadsak, Marcus Hacker, Markus Zeitlinger & Oliver Langer. (2017)
Effect of P-glycoprotein inhibition at the blood-brain barrier on brain distribution of (
R
)-[
11
C]verapamil in elderly
vs.
young subjects
. British Journal of Clinical Pharmacology 83:9, pages 1991-1999.
Crossref
Crossref
Akihiro Matsuda, Rudolf Karch, Martin Bauer, Alexander Traxl, Markus Zeitlinger & Oliver Langer. (2017) A Prediction Method for P-glycoprotein–Mediated Drug–Drug Interactions at the Human Blood–Brain Barrier From Blood Concentration–Time Profiles, Validated With PET Data. Journal of Pharmaceutical Sciences 106:9, pages 2780-2786.
Crossref
Crossref
Michal Stark & Yehuda G. Assaraf. (2017) Structural recognition of tubulysin B derivatives by multidrug resistance efflux transporters in human cancer cells. Oncotarget 8:30, pages 49973-49987.
Crossref
Crossref
Hadas Han, Aniv Mann, Dana Ekstein & Sara Eyal. (2017) Breaking Bad: the Structure and Function of the Blood-Brain Barrier in Epilepsy. The AAPS Journal 19:4, pages 973-988.
Crossref
Crossref
Yan Li, Jezrael Revalde & James W. Paxton. (2017) The effects of dietary and herbal phytochemicals on drug transporters. Advanced Drug Delivery Reviews 116, pages 45-62.
Crossref
Crossref
Ilaria Genovese, Andrea Ilari, Yehuda G. Assaraf, Francesco Fazi & Gianni Colotti. (2017) Not only P-glycoprotein: Amplification of the ABCB1- containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins. Drug Resistance Updates 32, pages 23-46.
Crossref
Crossref
Qianqian Qiu, Wei Shi, Zheng Li, Bo Zhang, Miaobo Pan, Jian Cui, Yuxuan Dai, Wenlong Huang & Hai Qian. (2017) Exploration of 2-((Pyridin-4-ylmethyl)amino)nicotinamide Derivatives as Potent Reversal Agents against P-Glycoprotein-Mediated Multidrug Resistance. Journal of Medicinal Chemistry 60:7, pages 2930-2943.
Crossref
Crossref
Samy A.F. Morad, Traci S. Davis, Matthew R. MacDougall, Su-Fern Tan, David J. Feith, Dhimant H. Desai, Shantu G. Amin, Mark Kester, Thomas P. LoughranJr.Jr. & Myles C. Cabot. (2017) Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer. Biochemical Pharmacology 130, pages 21-33.
Crossref
Crossref
Oliver Langer. 2017. Transporters as Drug Targets. Transporters as Drug Targets
179
198
.
Mi Kyoung Kim, Yunyoung Kim, Hyunah Choo & Youhoon Chong. (2017) Quercetin-glutamic acid conjugate with a non-hydrolysable linker; a novel scaffold for multidrug resistance reversal agents through inhibition of P-glycoprotein. Bioorganic & Medicinal Chemistry 25:3, pages 1219-1226.
Crossref
Crossref
Arefeh Rouhi, Christina Miller, Sarah Grasedieck, Stefanie Reinhart, Britta Stolze, Hartmut Döhner, Florian Kuchenbauer, Lars Bullinger, Stefan Fröhling & Claudia Scholl. (2016) Prospective identification of resistance mechanisms to HSP90 inhibition in KRAS mutant cancer cells. Oncotarget 8:5, pages 7678-7690.
Crossref
Crossref
Raafat El-Awady, Ekram Saleh, Amna Hashim, Nehal Soliman, Alaa Dallah, Azza Elrasheed & Ghada Elakraa. (2017) The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy. Frontiers in Pharmacology 7.
Crossref
Crossref
Femke E Froklage, Andrey Postnov, Maqsood M Yaqub, Esther Bakker, Ronald Boellaard, N Harry Hendrikse, Emile FI Comans, Robert C Schuit, Patrick Schober, Demetrios N Velis, Jack Zwemmer, Jan J Heimans, Adriaan A Lammertsma, Rob A Voskuyl & Jaap C Reijneveld. (2016)
Altered GABA
A
receptor density and unaltered blood–brain barrier [
11
C]flumazenil transport in drug-resistant epilepsy patients with mesial temporal sclerosis
. Journal of Cerebral Blood Flow & Metabolism 37:1, pages 97-105.
Crossref
Crossref
Joanna Kopecka, Gregory M. Rankin, Iris C. Salaroglio, Sally-Ann Poulsen & Chiara Riganti. (2016) P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors. Oncotarget 7:52, pages 85861-85875.
Crossref
Crossref
Abhijeet Deshmukh, Kedar Deshpande, Frank Arfuso, Philip Newsholme & Arun Dharmarajan. (2016) Cancer stem cell metabolism: a potential target for cancer therapy. Molecular Cancer 15:1.
Crossref
Crossref
Marloes J.A. Joosen, Stefanie M. Vester, Jouk Hamelink, Steven D. Klaassen & Roland M. van den Berg. (2016) Increasing nerve agent treatment efficacy by P-glycoprotein inhibition. Chemico-Biological Interactions 259, pages 115-121.
Crossref
Crossref
A Mann, H Han & S Eyal. (2016) Imaging transporters: Transforming diagnostic and therapeutic development. Clinical Pharmacology & Therapeutics 100:5, pages 479-488.
Crossref
Crossref
Yilin Zhang, Shravan Kumar Sriraman, Hilary A. Kenny, Ed Luther, Vladimir Torchilin & Ernst Lengyel. (2016) Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform. Molecular Cancer Therapeutics 15:10, pages 2282-2293.
Crossref
Crossref
Ziyan Fang, Shuda Chen, Jiaming Qin, Bao Chen, Guanzhong Ni, Ziyi Chen, Jueqian Zhou, Ze Li, Yuping Ning, Chuanbin Wu & Liemin Zhou. (2016) Pluronic P85-coated poly(butylcyanoacrylate) nanoparticles overcome phenytoin resistance in P-glycoprotein overexpressing rats with lithium-pilocarpine-induced chronic temporal lobe epilepsy. Biomaterials 97, pages 110-121.
Crossref
Crossref
Stefano Guglielmo, Loretta Lazzarato, Marialessandra Contino, Maria G. Perrone, Konstantin Chegaev, Antonio Carrieri, Roberta Fruttero, Nicola A. Colabufo & Alberto Gasco. (2016)
Structure–Activity Relationship Studies on Tetrahydroisoquinoline Derivatives: [4′-(6,7-Dimethoxy-3,4-dihydro-1
H
-isoquinolin-2-ylmethyl)biphenyl-4-ol] (
MC70
) Conjugated through Flexible Alkyl Chains with Furazan Moieties Gives Rise to Potent and Selective Ligands of P-glycoprotein
. Journal of Medicinal Chemistry 59:14, pages 6729-6738.
Crossref
Crossref
Wen Li, Han Zhang, Yehuda G. Assaraf, Kun Zhao, Xiaojun Xu, Jinbing Xie, Dong-Hua Yang & Zhe-Sheng Chen. (2016) Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies. Drug Resistance Updates 27, pages 14-29.
Crossref
Crossref
Oliver Langer. (2016) Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions. The Journal of Clinical Pharmacology 56, pages S143-S156.
Crossref
Crossref
Shubham Srivastava, Bhanwar Singh Choudhary, Manish Sharma & Ruchi Malik. (2016) Pharmacophore modeling and 3D-QSAR studies of galloyl benzamides as potent P-gp inhibitors. Medicinal Chemistry Research 25:6, pages 1140-1147.
Crossref
Crossref
Maya Bar-Zeev, Yehuda G. Assaraf & Yoav D. Livney. (2016) β-casein nanovehicles for oral delivery of chemotherapeutic drug combinations overcoming P-glycoprotein-mediated multidrug resistance in human gastric cancer cells. Oncotarget 7:17, pages 23322-23334.
Crossref
Crossref
Eduardo E. Chufan, Khyati Kapoor & Suresh V. Ambudkar. (2016) Drug–protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein. Biochemical Pharmacology 101, pages 40-53.
Crossref
Crossref
L. D. Weidner, K. L. Fung, P. Kannan, J. K. Moen, J. S. Kumar, J. Mulder, R. B. Innis, M. M. Gottesman & M. D. Hall. (2015) Tariquidar Is an Inhibitor and Not a Substrate of Human and Mouse P-glycoprotein. Drug Metabolism and Disposition 44:2, pages 275-282.
Crossref
Crossref
Jeyan S. Kumar, Lisa M. Miller Jenkins, Michael M. Gottesman & Matthew D. Hall. (2016)
The Drug Excipient Cyclodextrin Interacts With
d
-Luciferin and Interferes With Bioluminescence Imaging
. Molecular Imaging 15, pages 153601211562522.
Crossref
Crossref
Stergios Tsartsalis, Benjamin B. Tournier, Trinh Huynh-Gatz, Noé Dumas, Nathalie Ginovart, Marcelle Moulin-Sallanon & Philippe Millet. (2016) 5-HT2A receptor SPECT imaging with [ 123 I]R91150 under P-gp inhibition with tariquidar: More is better?. Nuclear Medicine and Biology 43:1, pages 81-88.
Crossref
Crossref
Bihter Atil, Evelyn Berger-Sieczkowski, Johanna Bardy, Martin Werner & Martin Hohenegger. (2015) In vitro and in vivo downregulation of the ATP binding cassette transporter B1 by the HMG-CoA reductase inhibitor simvastatin. Naunyn-Schmiedeberg's Archives of Pharmacology 389:1, pages 17-32.
Crossref
Crossref
Markus Zeitlinger. 2016. Clinical Pharmacology: Current Topics and Case Studies. Clinical Pharmacology: Current Topics and Case Studies
265
292
.
Agnes Basseville, Matthew D. Hall, Cindy H. Chau, Robert W. Robey, Michael Gottesman, William D. Figg & Susan E. Bates. 2016. ABC Transporters - 40 Years on. ABC Transporters - 40 Years on
195
226
.
Paul Slobbe, Albert D Windhorst, Marijke Stigter-van Walsum, Egbert F Smit, Heiko G Niessen, Flavio Solca, Gerd Stehle, Guus A M S van Dongen & Alex J Poot. (2015) A comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [11C]erlotinib and [18F]afatinib in lung cancer-bearing mice. EJNMMI Research 5:1.
Crossref
Crossref
Sarah J Reiling & Petra Rohrbach. (2015) Monitoring PfMDR1 transport in Plasmodium falciparum. Malaria Journal 14:1.
Crossref
Crossref
Sheng-qi Wang, Shi-ting Liu, Bo-xin Zhao, Fu-heng Yang, Ya-tian Wang, Qian-ying Liang, Ya-bin Sun, Yuan Liu, Zhi-hua Song, Yun Cai & Guo-feng Li. (2015) Afatinib reverses multidrug resistance in ovarian cancer via dually inhibiting ATP binding cassette subfamily B member 1. Oncotarget 6:28, pages 26142-26160.
Crossref
Crossref
Thomas Wanek, Kerstin Römermann, Severin Mairinger, Johann Stanek, Michael Sauberer, Thomas Filip, Alexander Traxl, Claudia Kuntner, Jens Pahnke, Florian Bauer, Thomas Erker, Wolfgang Löscher, Markus Müller & Oliver Langer. (2015) Factors Governing P-Glycoprotein-Mediated Drug–Drug Interactions at the Blood–Brain Barrier Measured with Positron Emission Tomography. Molecular Pharmaceutics 12:9, pages 3214-3225.
Crossref
Crossref
Michael M. Gottesman & Ira H. Pastan. (2015) The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene. Journal of the National Cancer Institute 107:9, pages djv222.
Crossref
Crossref
Ling-Lei Kong, Xiao-Mei zhuang, Hai-Ying Yang, Mei Yuan, Liang Xu & Hua Li. (2015) Inhibition of P-glycoprotein Gene Expression and Function Enhances Triptolide-induced Hepatotoxicity in Mice. Scientific Reports 5:1.
Crossref
Crossref
Thomas Wanek, Alexander Traxl, Jens P. Bankstahl, Marion Bankstahl, Michael Sauberer, Oliver Langer & Claudia Kuntner. (2015) [18F]FDG is not transported by P-glycoprotein and breast cancer resistance protein at the rodent blood–brain barrier. Nuclear Medicine and Biology 42:7, pages 585-589.
Crossref
Crossref
Renata Silva, Vânia Vilas-Boas, Helena Carmo, Ricardo Jorge Dinis-Oliveira, Félix Carvalho, Maria de Lourdes Bastos & Fernando Remião. (2015) Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy. Pharmacology & Therapeutics 149, pages 1-123.
Crossref
Crossref
RM Raaphorst, AD Windhorst, PH Elsinga, NA Colabufo, AA Lammertsma & G Luurtsema. (2015) Radiopharmaceuticals for assessing ABC transporters at the blood-brain barrier. Clinical Pharmacology & Therapeutics 97:4, pages 362-371.
Crossref
Crossref
Yanyan Zhang, Yidong Feng, Kodithuwakku Nandani Darshika, Bo Zhang, Yahui Hu, Weirong Fang, Yunman Li & Wenlong Huang. (2015) The effect of multidrug resistance modulator HZ08 on pharmacodynamics and pharmacokinetics of adriamycin in xenograft-nude mice. European Journal of Pharmaceutical Sciences 66, pages 109-117.
Crossref
Crossref
Carmen Avendaño & J. Carlos Menéndez. 2015. Medicinal Chemistry of Anticancer Drugs. Medicinal Chemistry of Anticancer Drugs
655
700
.
Zaigang Zhou, Xiaolei Tang, Yifan Zhang, Zheyi Hu, Jinhui Wu & Yiqiao Hu. (2014) L-1416, a novel MDR reversing agent with possible reduced calcium antagonism. Pharmacological Reports 66:6, pages 1140-1147.
Crossref
Crossref
Tip W. Loo & David M. Clarke. (2014) Tariquidar inhibits P-glycoprotein drug efflux but activates ATPase activity by blocking transition to an open conformation. Biochemical Pharmacology 92:4, pages 558-566.
Crossref
Crossref
Ravi S. Kasinathan, Lalit Kumar Sharma, Charles Cunningham, Thomas R. Webb & Robert M. Greenberg. (2014) Inhibition or Knockdown of ABC Transporters Enhances Susceptibility of Adult and Juvenile Schistosomes to Praziquantel. PLoS Neglected Tropical Diseases 8:10, pages e3265.
Crossref
Crossref
Hua Guo, Yuanyuan Liu, Yan Wang, Jing Wu, Xiaoying Yang, Rongshan Li, Yinsong Wang & Ning Zhang. (2014) pH-sensitive pullulan-based nanoparticle carrier for adriamycin to overcome drug-resistance of cancer cells. Carbohydrate Polymers 111, pages 908-917.
Crossref
Crossref
Mi Kyoung Kim, Hyunah Choo & Youhoon Chong. (2014) Water-Soluble and Cleavable Quercetin–Amino Acid Conjugates as Safe Modulators for P-Glycoprotein-Based Multidrug Resistance. Journal of Medicinal Chemistry 57:17, pages 7216-7233.
Crossref
Crossref
B Wulkersdorfer, T Wanek, M Bauer, M Zeitlinger, M Müller & O Langer. (2014) Using Positron Emission Tomography to Study Transporter-Mediated Drug–Drug Interactions in Tissues. Clinical Pharmacology & Therapeutics 96:2, pages 206-213.
Crossref
Crossref
Mayur Yergeri, Sonali Kapse-Mistry, Rohit Srivastava & Thirumala Govender. (2014) Nanodrug delivery in reversing multidrug resistance in cancer cells. Frontiers in Pharmacology 5.
Crossref
Crossref
Dana Alms, Maren Fedrowitz, Kerstin Römermann, Andreas Noack & Wolfgang Löscher. (2014) Marked Differences in the Effect of Antiepileptic and Cytostatic Drugs on the Functionality of P-Glycoprotein in Human and Rat Brain Capillary Endothelial Cell Lines. Pharmaceutical Research 31:6, pages 1588-1604.
Crossref
Crossref
Sarah M. Bouhired, Max Crüsemann, Celso Almeida, Tilmann Weber, Jörn Piel, Till F. Schäberle & Gabriele M. König. (2014)
Biosynthesis of Phenylnannolone A, a Multidrug Resistance Reversal Agent from the Halotolerant Myxobacterium
Nannocystis pusilla
B150
. ChemBioChem 15:5, pages 757-765.
Crossref
Crossref
Dioxelis Lopez & Sergio Martinez-Luis. (2014) Marine Natural Products with P-Glycoprotein Inhibitor Properties. Marine Drugs 12:1, pages 525-546.
Crossref
Crossref
Satyakam Singh, Nagarajan Rajendra Prasad, Khyati Kapoor, Eduardo E. Chufan, Bhargav A. Patel, Suresh V. Ambudkar & Tanaji T. Talele. (2014)
Design, Synthesis, and Biological Evaluation of (
S
)-Valine Thiazole-Derived Cyclic and Noncyclic Peptidomimetic Oligomers as Modulators of Human P-Glycoprotein (ABCB1)
. ChemBioChem 15:1, pages 157-169.
Crossref
Crossref
Richard B. Silverman & Mark W. Holladay. 2014. The Organic Chemistry of Drug Design and Drug Action. The Organic Chemistry of Drug Design and Drug Action
333
356
.
Tristan M. Sissung, Andrew K. L. Goey, Ariel M. Ley, Jonathan D. Strope & William D. Figg. 2014. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development
91
120
.
Paul R. Massey, Tito Fojo & Susan E. Bates. 2014. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
373
400
.
Elizabeth CM de Lange. (2013) The mastermind approach to CNS drug therapy: translational prediction of human brain distribution, target site kinetics, and therapeutic effects. Fluids and Barriers of the CNS 10:1.
Crossref
Crossref
Ilza K. Pajeva, Katja Sterz, Matthias Christlieb, Kerstin Steggemann, Federico Marighetti & Michael Wiese. (2013) Interactions of the Multidrug Resistance Modulators Tariquidar and Elacridar and their Analogues with P-glycoprotein. ChemMedChem, pages n/a-n/a.
Crossref
Crossref
Fan Bai, Chao Wang, Qin Lu, Mei Zhao, Fu-Qiang Ban, De-Hong Yu, Ying-Yun Guan, Xin Luan, Ya-Rong Liu, Hong-Zhuan Chen & Chao Fang. (2013) Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer. Biomaterials 34:26, pages 6163-6174.
Crossref
Crossref
David Dickens, Andrew Owen, Ana Alfirevic & Munir Pirmohamed. (2013) ABCB1 single nucleotide polymorphisms (1236C>T, 2677G>T, and 3435C>T) do not affect transport activity of human P-glycoprotein. Pharmacogenetics and Genomics 23:6, pages 314-323.
Crossref
Crossref
Joost Westerhout, Jean Smeets, Meindert Danhof & Elizabeth C. M. de Lange. (2013) The impact of P-gp functionality on non-steady state relationships between CSF and brain extracellular fluid. Journal of Pharmacokinetics and Pharmacodynamics 40:3, pages 327-342.
Crossref
Crossref
Man Yu, Alberto Ocana & Ian F. Tannock. (2012) Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?. Cancer and Metastasis Reviews 32:1-2, pages 211-227.
Crossref
Crossref
Xiao-cong Huang, Yue-Li Sun, Angela A. Salim, Zhe-Sheng Chen & Robert J. Capon. (2013) Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells. Biochemical Pharmacology 85:9, pages 1257-1268.
Crossref
Crossref
Jasna Banković, Jörg Andrä, Nataša Todorović, Ana Podolski-Renić, Zorica Milošević, Đorđe Miljković, Jannike Krause, Sabera Ruždijić, Nikola Tanić & Milica Pešić. (2013) The elimination of P-glycoprotein over-expressing cancer cells by antimicrobial cationic peptide NK-2: The unique way of multi-drug resistance modulation. Experimental Cell Research 319:7, pages 1013-1027.
Crossref
Crossref
Thomas Wanek, Severin Mairinger & Oliver Langer. (2013) Radioligands targeting P‐glycoprotein and other drug efflux proteins at the blood–brain barrier. Journal of Labelled Compounds and Radiopharmaceuticals 56:3-4, pages 68-77.
Crossref
Crossref
Yue-Li Sun, Jun-Jiang Chen, Priyank Kumar, Kang Chen, Kamlesh Sodani, Atish Patel, Yang-Lu Chen, Si-Dong Chen, Wen-Qi Jiang & Zhe-Sheng Chen. (2013) Reversal of MRP7 (ABCC10)-Mediated Multidrug Resistance by Tariquidar. PLoS ONE 8:2, pages e55576.
Crossref
Crossref
Milka Jadranin, Milica Pešić, Ivana S. Aljančić, Slobodan M. Milosavljević, Nina M. Todorović, Ana Podolski-Renić, Jasna Banković, Nikola Tanić, Ivanka Marković, Vlatka E. Vajs & Vele V. Tešević. (2013) Jatrophane diterpenoids from the latex of Euphorbia dendroides and their anti-P-glycoprotein activity in human multi-drug resistant cancer cell lines. Phytochemistry 86, pages 208-217.
Crossref
Crossref
Hans JC Buiter, Albert D Windhorst, Marc C Huisman, Joris H De Maeyer, Jan AJ Schuurkes, Adriaan A Lammertsma & Josée E Leysen. (2013) Radiosynthesis and preclinical evaluation of [11C]prucalopride as a potential agonist PET ligand for the 5-HT4 receptor. EJNMMI Research 3:1, pages 24.
Crossref
Crossref
M. Bauer, M. Zeitlinger, D. Todorut, M. Böhmdorfer, M. Müller, O. Langer & W. Jäger. (2013) Pharmacokinetics of Single Ascending Doses of the P-Glycoprotein Inhibitor Tariquidar in Healthy Subjects. Pharmacology 91:1-2, pages 12-19.
Crossref
Crossref
Dennis Hernandez, Paul Falk, Fei Yu, Guangzhi Zhai, Yong Quan, Teresa Faria, Kai Cao, Paul Scola & Fiona McPhee. (2013) Establishment of a robust hepatitis C virus replicon cell line over-expressing P-glycoprotein that facilitates analysis of P-gp drug transporter effects on inhibitor antiviral activity. Biochemical Pharmacology 85:1, pages 21-28.
Crossref
Crossref
Heidrun Potschka. 2013. Pharmacoresistance in Epilepsy. Pharmacoresistance in Epilepsy
225
232
.
Alan Talevi & Luis E. Bruno-Blanch. 2013. Pharmacoresistance in Epilepsy. Pharmacoresistance in Epilepsy
207
224
.
Femke E Froklage, Stina Syvänen, N Harry Hendrikse, Marc C Huisman, Carla FM Molthoff, Yoshihiko Tagawa, Jaap C Reijneveld, Jan J Heimans, Adriaan A Lammertsma, Jonas Eriksson, Elizabeth CM de Lange & Rob A Voskuyl. (2012) [11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoprotein. EJNMMI Research 2:1.
Crossref
Crossref
Cindy Q. Xia & Peter G. Smith. (2012) Drug Efflux Transporters and Multidrug Resistance in Acute Leukemia: Therapeutic Impact and Novel Approaches to Mediation. Molecular Pharmacology 82:6, pages 1008-1021.
Crossref
Crossref
Yan Xu, Feng Zhi, Guangming Xu, Xiaolei Tang, Sheng Lu, Jinhui Wu & Yiqiao Hu. (2012)
Overcoming multidrug-resistance
in vitro
and
in vivo
using the novel P-glycoprotein inhibitor 1416
. Bioscience Reports 32:6, pages 559-566.
Crossref
Crossref
Florian Bauer, Thomas Wanek, Severin Mairinger, Johann Stanek, Michael Sauberer, Claudia Kuntner, Zahida Parveen, Peter Chiba, Markus Müller, Oliver Langer & Thomas Erker. (2012) Interaction of HM30181 with P-glycoprotein at the murine blood–brain barrier assessed with positron emission tomography. European Journal of Pharmacology 696:1-3, pages 18-27.
Crossref
Crossref
Samuel W. Gerritz, Weixu Zhai, Shuhao Shi, Shirong Zhu, Jeremy H. Toyn, Jere E. MeredithJr.Jr., Lawrence G. Iben, Catherine R. Burton, Charles F. Albright, Andrew C. Good, Andrew J. Tebben, Jodi K. Muckelbauer, Daniel M. Camac, William Metzler, Lynda S. Cook, Ramesh Padmanabha, Kimberley A. Lentz, Michael J. Sofia, Michael A. Poss, John E. Macor & Lorin A. ThompsonIIIIII. (2012) Acyl Guanidine Inhibitors of β-Secretase (BACE-1): Optimization of a Micromolar Hit to a Nanomolar Lead via Iterative Solid- and Solution-Phase Library Synthesis. Journal of Medicinal Chemistry 55:21, pages 9208-9223.
Crossref
Crossref
Thomas Wanek, Claudia Kuntner, Jens P Bankstahl, Severin Mairinger, Marion Bankstahl, Johann Stanek, Michael Sauberer, Thomas Filip, Thomas Erker, Markus Müller, Wolfgang Löscher & Oliver Langer. (2012) A Novel PET Protocol for Visualization of Breast Cancer Resistance Protein Function at the Blood–Brain Barrier. Journal of Cerebral Blood Flow & Metabolism 32:11, pages 2002-2011.
Crossref
Crossref
Stefania Nobili, Ida Landini, Teresita Mazzei & Enrico Mini. (2011) Overcoming tumor multidrug resistance using drugs able to evade P‐glycoprotein or to exploit its expression. Medicinal Research Reviews 32:6, pages 1220-1262.
Crossref
Crossref
Jing Wu, Yin-song Wang, Xiao-ying Yang, Yuan-yuan Liu, Jin-rong Yang, Rui Yang & Ning Zhang. (2012) Graphene oxide used as a carrier for adriamycin can reverse drug resistance in breast cancer cells. Nanotechnology 23:35, pages 355101.
Crossref
Crossref
Tip W. Loo, M. Claire Bartlett, Michael R. Detty & David M. Clarke. (2012) The ATPase Activity of the P-glycoprotein Drug Pump Is Highly Activated When the N-terminal and Central Regions of the Nucleotide-binding Domains Are Linked Closely Together. Journal of Biological Chemistry 287:32, pages 26806-26816.
Crossref
Crossref
Heidrun Potschka. (2012) Role of CNS efflux drug transporters in antiepileptic drug delivery: Overcoming CNS efflux drug transport. Advanced Drug Delivery Reviews 64:10, pages 943-952.
Crossref
Crossref
Severin Mairinger, Jens P. Bankstahl, Claudia Kuntner, Kerstin Römermann, Marion Bankstahl, Thomas Wanek, Johann Stanek, Wolfgang Löscher, Markus Müller, Thomas Erker & Oliver Langer. (2012) The antiepileptic drug mephobarbital is not transported by P-glycoprotein or multidrug resistance protein 1 at the blood–brain barrier: A positron emission tomography study. Epilepsy Research 100:1-2, pages 93-103.
Crossref
Crossref
M Bauer, M Zeitlinger, R Karch, P Matzneller, J Stanek, W Jäger, M Böhmdorfer, W Wadsak, M Mitterhauser, J P Bankstahl, W Löscher, M Koepp, C Kuntner, M Müller & Oliver Langer. (2011) Pgp-Mediated Interaction Between (R)-[11C]Verapamil and Tariquidar at the Human Blood–Brain Barrier: A Comparison With Rat Data. Clinical Pharmacology & Therapeutics 91:2, pages 227-233.
Crossref
Crossref
Kristen M. Pluchino, Matthew D. Hall, Andrew S. Goldsborough, Richard Callaghan & Michael M. Gottesman. (2012) Collateral sensitivity as a strategy against cancer multidrug resistance. Drug Resistance Updates 15:1-2, pages 98-105.
Crossref
Crossref
Displaying 200 of 261 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list